These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 6271051)

  • 1. In vitro and in vivo morphological response of Klebsiella pneumoniae to cefotiam and cefazolin.
    Nakao M; Nishi T; Tsuchiya K
    Antimicrob Agents Chemother; 1981 May; 19(5):901-10. PubMed ID: 6271051
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relevance of in vitro antibacterial activities of cefotiam and cefazolin to their therapeutic effects on experimental pneumonia caused by Klebsiella pneumoniae DT-S in mice.
    Nishi T; Nakao M; Tsuchiya K
    J Antibiot (Tokyo); 1981 Feb; 34(2):231-9. PubMed ID: 6271719
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic effects of cefotiam and cefazolin on experimental pneumonia caused by Klebsiella pneumoniae DT-S in mice.
    Nishi T; Tsuchiya K
    Antimicrob Agents Chemother; 1980 Oct; 18(4):549-56. PubMed ID: 7004342
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic activities of cefazolin, cefotaxime, and ceftazidime against experimentally induced Klebsiella pneumoniae pneumonia in rats.
    Bakker-Woudenberg IA; van den Berg JC; Michel MF
    Antimicrob Agents Chemother; 1982 Dec; 22(6):1042-50. PubMed ID: 6297384
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relevance of serum protein binding of cefoxitin and cefazolin to their activities against Klebsiella pneumoniae pneumonia in rats.
    Bakker-Woudenberg IA; van den Berg JC; Vree TB; Baars AM; Michel MF
    Antimicrob Agents Chemother; 1985 Nov; 28(5):654-9. PubMed ID: 3911879
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cefodizime, an aminothiazolyl cephalosporin. III. Therapeutic activity against experimentally induced pneumonia in mice.
    Klesel N; Limbert M; Seibert G; Winkler I; Schrinner E
    J Antibiot (Tokyo); 1984 Dec; 37(12):1712-8. PubMed ID: 6098572
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of ceftazidime in experimental Klebsiella pneumoniae pneumonia: comparison with other antibiotics and measurement of its penetration into respiratory tissues and secretions.
    McColm AA; Shelley E; Ryan DM; Acred P
    J Antimicrob Chemother; 1986 Nov; 18(5):599-608. PubMed ID: 3542926
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative effects of cefpirome (HR 810) and other cephalosporins on experimentally induced pneumonia in mice.
    Klesel N; Isert D; Limbert M; Seibert G; Winkler I; Schrinner E
    J Antibiot (Tokyo); 1986 Jul; 39(7):971-7. PubMed ID: 3531131
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Laboratory evaluation of cefmenoxime: a new cephalosporin. In vitro and in vivo antibacterial activities and pharmacokinetic properties.
    Matsumoto K; Nagatake T; Uzuka Y; Harada T; Rikitomi N
    Chemotherapy; 1983; 29(2):80-8. PubMed ID: 6301776
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative in vitro activities of temocillin and cefazolin against Klebsiella pneumoniae.
    Lagast H; Klastersky J
    Antimicrob Agents Chemother; 1982 Aug; 22(2):330-1. PubMed ID: 6765417
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antimicrobial polymers as therapeutics for treatment of multidrug-resistant Klebsiella pneumoniae lung infection.
    Lou W; Venkataraman S; Zhong G; Ding B; Tan JPK; Xu L; Fan W; Yang YY
    Acta Biomater; 2018 Sep; 78():78-88. PubMed ID: 30031912
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of cefodizime on pulmonary inflammatory response to heat-killed Klebsiella pneumoniae in mice.
    Bergeron Y; Deslauriers AM; Ouellet N; Gauthier MC; Bergeron MG
    Antimicrob Agents Chemother; 1999 Sep; 43(9):2291-4. PubMed ID: 10471581
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Application of mathematical model to multiple-dose experimental chemotherapy for fatal murine pneumonia.
    Hishikawa T; Kusunoki T; Tsuchiya K; Uzuka Y; Sakamoto T; Nagatake T; Matsumoto K
    Antimicrob Agents Chemother; 1991 Jun; 35(6):1066-9. PubMed ID: 1929244
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of antibacterial in vitro activity of moxifloxacin and its effects on pulmonary clearance of Klebsiella pneumoniae in an animal experimental model.
    Drago L; De Vecchi E; Nicola L; Gismondo MR
    Arzneimittelforschung; 2005; 55(8):473-7. PubMed ID: 16149716
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Basic and clinical studies of cefotiam in pediatric field (author's transl)].
    Nishimura T; Hiromatsu K; Takashima T; Tabuki K; Kotani Y
    Jpn J Antibiot; 1981 Jun; 34(6):1027-36. PubMed ID: 6270419
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of two penicillins plus beta-lactamase inhibitors versus cefotaxime in treatment of murine Klebsiella pneumoniae infections.
    Fournier JL; Ramisse F; Jacolot AC; Szatanik M; Petitjean OJ; Alonso JM; Scavizzi MR
    Antimicrob Agents Chemother; 1996 Feb; 40(2):325-30. PubMed ID: 8834874
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Another look at differences in the susceptibility of Escherichia coli and Klebsiella pneumoniae to cephalothin and cefazolin.
    Yeh LL; Chi CL
    Int J Antimicrob Agents; 2001 Jun; 17(6):521-4. PubMed ID: 11397625
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of revised susceptibility breakpoints on bacteremia of Klebsiella pneumoniae: Minimum inhibitory concentration of cefazolin and clinical outcomes.
    Chuang CH; Liu MF; Lin CF; Shi ZY
    J Microbiol Immunol Infect; 2016 Oct; 49(5):679-684. PubMed ID: 25442869
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative activities of cefotiam and cefazolin against urinary tract infections with Proteus mirabilis in mice.
    Iwahi T; Tsuchiya K
    Antimicrob Agents Chemother; 1980 Aug; 18(2):257-63. PubMed ID: 7004338
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo antibacterial activity of cefodizime, a new cephalosporin antibiotic.
    Kasai K; Tsuji A; Miyazaki S; Goto S; Fujimoto K; Masuyoshi S; Arai S
    Jpn J Antibiot; 1984 Jul; 37(7):1306-12. PubMed ID: 6092740
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.